Want to see RVTY full AI Analyst Report?

Revvity (RVTY) Stock Forecast & Price Target

571 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

RVTY Analyst Ratings

Moderate Buy

5 Buy

9 Hold

0 Sell

Based on 14 analysts giving stock ratings to

Revvity

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

RVTY Stock 12 Month Forecast

Average Price Target

$127.36

▼(-1.81% Downside)

Based on 14 Wall Street analysts offering 12 month price targets for Revvity in the last 3 months. The average price target is $127.36 with a high forecast of $165.00 and a low forecast of $110.00. The average price target represents a -1.81% change from the last price of $129.71.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"85":"$85","166":"$166","105.25":"$105.3","125.5":"$125.5","145.75":"$145.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":165,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$165.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":127.36363636363636,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$127.36</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":110,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$110.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[85,105.25,125.5,145.75,166],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,149.06,150.28615384615384,151.5123076923077,152.73846153846154,153.9646153846154,155.19076923076923,156.41692307692307,157.64307692307693,158.86923076923077,160.0953846153846,161.32153846153847,162.5476923076923,163.77384615384616,{"y":165,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,149.06,147.39104895104896,145.72209790209791,144.05314685314684,142.3841958041958,140.71524475524475,139.0462937062937,137.37734265734267,135.7083916083916,134.03944055944055,132.3704895104895,130.70153846153846,129.03258741258742,{"y":127.36363636363636,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,149.06,146.0553846153846,143.05076923076922,140.04615384615386,137.04153846153847,134.03692307692307,131.03230769230768,128.02769230769232,125.02307692307693,122.01846153846154,119.01384615384616,116.00923076923077,113.00461538461539,{"y":110,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":91.506,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":93.401,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":102.223,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":96.555,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":106.939,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.455,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.796,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":86.625,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":100.457,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":112.769,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":112.52,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":126.59,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":149.06,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$165.00

Average Price Target$127.36

Lowest Price Target$110.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Matt Larew

William Blair

―

Buy

―

Initiated

10/05/26

Revvity initiated with an Outperform at William BlairRevvity initiated with an Outperform at William Blair

Eve Burstein

Bernstein

$120

Hold

-7.49%

Downside

Reiterated

09/25/26

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (NASDAQ: ALNY) and Revvity (NYSE: RVTY)

Evie Koslosky

Goldman Sachs

$100→$140

Hold

7.93%

Upside

Reiterated

09/20/26

Goldman Sachs Remains a Hold on Revvity (RVTY)

Unknown Analyst

CFRA

Not Ranked

CFRA

―

Hold

―

Downgraded

09/18/26

CFRA downgrades Revvity (RVTY) to a Hold

Unknown Analyst

UBS

Not Ranked

UBS

$120→$140

Hold

7.93%

Upside

Initiated

09/08/26

Revvity (RVTY) Receives a New Rating from UBS

Paul Knight

KeyBanc

$125→$165

Buy

27.21%

Upside

Reiterated

09/04/26

KeyBanc Sticks to Their Buy Rating for Revvity (RVTY)

Dan Leonard

RBC Capital

$135

Hold

4.08%

Upside

Initiated

09/01/26

Revvity initiated with a Sector Perform at RBC CapitalRevvity initiated with a Sector Perform at RBC Capital

Daniel Brennan

TD Cowen

$130

Buy

0.22%

Upside

Assigned

08/07/26

Revvity: Solid Q2, Raised Guidance and AI‑Driven Backlog Support Buy Rating and $130 Price Target

Casey Woodring

J.P. Morgan

$110

Hold

-15.20%

Downside

Reiterated

08/06/26

J.P. Morgan Reaffirms Their Hold Rating on Revvity (RVTY)

Daniel Arias

Stifel Nicolaus

$100→$110

Hold

-15.20%

Downside

Assigned

08/05/26

Revvity price target raised to $110 from $100 at StifelRevvity price target raised to $110 from $100 at Stifel

Vijay Kumar

Evercore ISI

$125→$126

Buy

-2.86%

Downside

Reiterated

08/05/26

Revvity price target raised to $126 from $125 at Evercore ISIRevvity price target raised to $126 from $125 at Evercore ISI

Evan Stampler

Wells Fargo

$110

Hold

-15.20%

Downside

Reiterated

08/05/26

Wells Fargo Sticks to Its Hold Rating for Revvity (RVTY)

Luke Sergott

Barclays

$105→$115

Hold

-11.34%

Downside

Reiterated

08/04/26

Puneet Souda

Leerink Partners

―

Buy

―

Reiterated

07/17/26

Revvity (RVTY) Receives a Buy from Leerink Partners

Michael Polark

Wolfe Research

―

Hold

―

Initiated

06/01/26

Revvity assumed with a Peer Perform at Wolfe ResearchRevvity assumed with a Peer Perform at Wolfe Research

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Matt Larew

William Blair

―

Buy

―

Initiated

10/05/26

Revvity initiated with an Outperform at William BlairRevvity initiated with an Outperform at William Blair

Eve Burstein

Bernstein

$120

Hold

-7.49%

Downside

Reiterated

09/25/26

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (NASDAQ: ALNY) and Revvity (NYSE: RVTY)

Evie Koslosky

Goldman Sachs

$100→$140

Hold

7.93%

Upside

Reiterated

09/20/26

Goldman Sachs Remains a Hold on Revvity (RVTY)

Unknown Analyst

CFRA

Not Ranked

CFRA

―

Hold

―

Downgraded

09/18/26

CFRA downgrades Revvity (RVTY) to a Hold

Unknown Analyst

UBS

Not Ranked

UBS

$120→$140

Hold

7.93%

Upside

Initiated

09/08/26

Revvity (RVTY) Receives a New Rating from UBS

Paul Knight

KeyBanc

$125→$165

Buy

27.21%

Upside

Reiterated

09/04/26

KeyBanc Sticks to Their Buy Rating for Revvity (RVTY)

Dan Leonard

RBC Capital

$135

Hold

4.08%

Upside

Initiated

09/01/26

Revvity initiated with a Sector Perform at RBC CapitalRevvity initiated with a Sector Perform at RBC Capital

Daniel Brennan

TD Cowen

$130

Buy

0.22%

Upside

Assigned

08/07/26

Revvity: Solid Q2, Raised Guidance and AI‑Driven Backlog Support Buy Rating and $130 Price Target

Casey Woodring

J.P. Morgan

$110

Hold

-15.20%

Downside

Reiterated

08/06/26

J.P. Morgan Reaffirms Their Hold Rating on Revvity (RVTY)

Daniel Arias

Stifel Nicolaus

$100→$110

Hold

-15.20%

Downside

Assigned

08/05/26

Revvity price target raised to $110 from $100 at StifelRevvity price target raised to $110 from $100 at Stifel

Vijay Kumar

Evercore ISI

$125→$126

Buy

-2.86%

Downside

Reiterated

08/05/26

Revvity price target raised to $126 from $125 at Evercore ISIRevvity price target raised to $126 from $125 at Evercore ISI

Evan Stampler

Wells Fargo

$110

Hold

-15.20%

Downside

Reiterated

08/05/26

Wells Fargo Sticks to Its Hold Rating for Revvity (RVTY)

Luke Sergott

Barclays

$105→$115

Hold

-11.34%

Downside

Reiterated

08/04/26

Puneet Souda

Leerink Partners

―

Buy

―

Reiterated

07/17/26

Revvity (RVTY) Receives a Buy from Leerink Partners

Michael Polark

Wolfe Research

―

Hold

―

Initiated

06/01/26

Revvity assumed with a Peer Perform at Wolfe ResearchRevvity assumed with a Peer Perform at Wolfe Research

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

KURAKura Oncology

DNLIDenali Therapeutics

OVIDOvid Therapeutics

HITIHigh Tide

AXGNAxoGen

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Revvity

3 Months

Catherine Ramsey SchulteRobert W. Baird

Success Rate

24/37 ratings generated profit

Average Return

+3.05%

Copying Catherine Ramsey Schulte's trades and holding each position for 3 Months would result in 64.86% of your transactions generating a profit, with an average return of +3.05% per trade.

1 Year

Daniel BrennanTD Cowen

Success Rate

11/16 ratings generated profit

Average Return

+22.04%

Copying Daniel Brennan's trades and holding each position for 1 Year would result in 68.75% of your transactions generating a profit, with an average return of +22.04% per trade.

2 Years

Daniel BrennanTD Cowen

Success Rate

14/16 ratings generated profit

Average Return

+34.76%

Copying Daniel Brennan's trades and holding each position for 2 Years would result in 87.50% of your transactions generating a profit, with an average return of +34.76% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

RVTY Analyst Recommendation Trends

Rating

Jun 26

Jul 26

Aug 26

Sep 26

Oct 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, RVTY has received 4 Buy Ratings, 11 Hold Ratings, and 0 Sell Ratings. RVTY average Analyst price target in the past 3 months is 127.36.

Each month's total comprises the sum of three months' worth of ratings.

RVTY Financial Forecast

RVTY Earnings Forecast

Next quarter’s earnings estimate for RVTY is $1.29 with a range of $1.28 to $1.33. The previous quarter’s EPS was $1.41. RVTY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year RVTY has Performed in-line its overall industry.

RVTY Sales Forecast

Next quarter’s sales forecast for RVTY is $694.51M with a range of $690.60M to $703.00M. The previous quarter’s sales results were $729.69M. RVTY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year RVTY has Performed in-line its overall industry.

RVTY Stock Forecast FAQ

What is RVTY’s average 12-month price target, according to analysts?

Based on analyst ratings, Revvity’s 12-month average price target is 127.36.

What is RVTY’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for RVTY, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is RVTY a Buy, Sell or Hold?

Revvity has a consensus rating of Moderate Buy which is based on 5 buy ratings, 9 hold ratings and 0 sell ratings.

What is Revvity’s price target?

The average price target for Revvity is 127.36. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $165.00 ,the lowest forecast is $110.00. The average price target represents -1.81% Decrease from the current price of $129.71.

What do analysts say about Revvity?

Revvity’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 14 Wall Streets Analysts.

How can I buy shares of RVTY?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Revvity (RVTY) Stock Forecast & Price Target

RVTY Analyst Ratings

RVTY Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Revvity

RVTY Analyst Recommendation Trends

RVTY Financial Forecast

RVTY Earnings Forecast

RVTY Sales Forecast

RVTY Stock Forecast FAQ

Detailed List of Analyst Forecasts